135 related articles for article (PubMed ID: 15248826)
1. Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment.
D'Ascenzo S; Giusti I; Millimaggi D; Marci R; Tatone C; Cardigno Colonna R; Moscarini M; Pavan A; Dolo V; Caserta D
Eur J Endocrinol; 2004 Jul; 151(1):87-91. PubMed ID: 15248826
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of tissue inhibitor of matrix metalloproteinases in follicular fluid from women with polycystic ovaries compared with normally ovulating patients undergoing in vitro fertilization.
Lahav-Baratz S; Kraiem Z; Shiloh H; Koifman M; Ishai D; Dirnfeld M
Fertil Steril; 2003 Mar; 79(3):567-71. PubMed ID: 12620441
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation.
Baka S; Zourla K; Kouskouni E; Makrakis E; Demeridou S; Tzanakaki D; Hassiakos D; Creatsas G
In Vivo; 2010; 24(3):293-6. PubMed ID: 20555001
[TBL] [Abstract][Full Text] [Related]
4. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
[TBL] [Abstract][Full Text] [Related]
6. Altered circulating levels of matrix metalloproteinases 2 and 9 and their inhibitors and effect of progesterone supplementation in women with endometriosis undergoing in vitro fertilization.
Singh AK; Chattopadhyay R; Chakravarty B; Chaudhury K
Fertil Steril; 2013 Jul; 100(1):127-34.e1. PubMed ID: 23557756
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
[TBL] [Abstract][Full Text] [Related]
8. The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women.
Shalev E; Goldman S; Ben-Shlomo I
Mol Hum Reprod; 2001 Apr; 7(4):325-31. PubMed ID: 11279294
[TBL] [Abstract][Full Text] [Related]
9. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat.
Curry TE; Song L; Wheeler SE
Biol Reprod; 2001 Sep; 65(3):855-65. PubMed ID: 11514351
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
[TBL] [Abstract][Full Text] [Related]
12. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Tayebjee MH; Lip GY; Blann AD; Macfadyen RJ
Thromb Res; 2005; 115(3):205-10. PubMed ID: 15617743
[TBL] [Abstract][Full Text] [Related]
13. [Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study].
Bogusiewicz M; Stryjecka-Zimmer M; Rechberger T
Ginekol Pol; 2007 May; 78(5):366-72. PubMed ID: 17867327
[TBL] [Abstract][Full Text] [Related]
14. [Concentrations of MMP-1, TIMP-1, MMP-1/TIMP-1 and I CTP complexes in follicular fluid as related to fertilization rate in women treated with in-vitro fertilization].
Grabiec M; Szymański W; Szymański M; Jendryczka J; Polak G; Gogacz M; Rechberger T
Ginekol Pol; 2001 Mar; 72(3):107-12. PubMed ID: 11398577
[TBL] [Abstract][Full Text] [Related]
15. Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro.
Sessions DR; Vick MM; Fitzgerald BP
J Anim Sci; 2009 Dec; 87(12):3955-66. PubMed ID: 19684269
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
17. [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma].
Chen Y; Tian K; Geng N; Yang MZ; Zhang WP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):58-61. PubMed ID: 15774155
[TBL] [Abstract][Full Text] [Related]
18. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Giannelli G; Erriquez R; Iannone F; Marinosci F; Lapadula G; Antonaci S
Clin Exp Rheumatol; 2004; 22(3):335-8. PubMed ID: 15144129
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinases and their inhibitors in the internal carotid artery wall in pathological tortuosity].
Paltseva EM; Polyakova VO; Oskolkova SA; Abramyan AV; Ivanova AG; Krylova YS; Gavrilenko AV
Arkh Patol; 2016; 78(3):26-31. PubMed ID: 27296003
[TBL] [Abstract][Full Text] [Related]
20. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
